
	Home Site Map Contact Links Medical News

antegren fda approval

antegren
Compare Prices on antegren and More.Get the Best Deal at BottomDollar.com!

antegren fda approval
Biogen Idec and Elan Announce Intention to Submit for Approval for Multiple SclerosisBased on One-Year Data

CAMBRIDGE, Mass antegren fda approval. & SAN DIEGO & DUBLIN, Ireland--February 18, 2004--BiogenIdec and Elan Corporation, plc today announced that they expect to submit tothe U.S antegren fda approval. Food and Drug Administration (FDA) an application for approval of Antegren(natalizumab) as a treatment for multiple sclerosis (MS) antegren fda approval. The companies expectto submit the filing mid-year 2004.

The decision to file a Biologics License Application (BLA) was made after discussionswith the FDA of one-year data from the two ongoing two-year Phase III trialsin MS antegren fda approval. The companies are committed to completing the two-year trials antegren fda approval. To protectthe integrity of the trials, the companies are not disclosing the one-year dataat this time.

Biogen Idec and Elan are collaborating equally on the development of natalizumabfor MS, Crohn's disease, and rheumatoid arthritis.

About the Antegren MS Clinical Trials
The AFFIRM (natalizumab safety and efficacy in relapsing-remitting MS) trialis a two-year, randomized, multi-center, placebo-controlled, double-blind studyof approximately 900 patients, evaluating the ability of natalizumab to slowthe progression of disability in MS and reduce the rate of clinical relapses antegren fda approval. The SENTINEL (safety and efficacy of natalizumab in combination with Avonex(Interferon beta-1a)) trial is a two-year, randomized, multi-center, placebo-controlled,double-blind study of approximately 1,200 patients with relapsing-remittingMS, evaluating the effect of the combination of natalizumab and Avonex comparedto treatment with Avonex alone in slowing the progression of disability andreducing the rate of clinical relapses antegren fda approval. Both studies have protocols that includeda one-year analysis of the data antegren fda approval. The primary endpoints for both Phase III two-yeartrials in MS are based on the Expanded Disability Status Scale (EDSS) and relapserates antegren fda approval. The pre-specified primary endpoint of the one-year analysis was relapserates.

About Antegren (natalizumab)
Natalizumab, a humanized monoclonal antibody, is the first alpha-4 antagonistin the new SAM (selective adhesion molecule) inhibitor class antegren fda approval. The drug was designedto selectively inhibit immune cells from leaving the bloodstream and to preventthese cells from migrating into chronically inflamed tissue as occurs in a varietyof inflammatory diseases antegren fda approval. To date, approximately 2,800 patients have receivednatalizumab in clinical studies antegren fda approval. In previous clinical trials, the followingadverse events occurred more commonly with natalizumab when compared to placebo:headache, nausea, abdominal pain, infection, urinary tract infection, pharyngitisand rash antegren fda approval. Serious adverse events have included infrequent hypersensitivity-likereactions.

antegren news antegren ms antegren antegren side effects antegren ms antegren experience antegren multiple sclerosis antegren rumors biogen antegren how to take antegren new news on antegren antegren and administer antegren updates side effects antegren antegren has approved antegren infusion antegren news antegren malaga antegren antegren and ms antegren has approved antegren sentinel study antegren therapy antegren multiple sclerosis manufacture of antegren antegren experience antegren and administer antegren approval antegren antegren and alt crohn antegren side effects antegren logo antegren and administer potential problems with antegren antegren and multiple sclerosis antegren jama fda antegren ruling antegren therapy antegren updates antegren malaga antegren + headaches antegren logo antegren approval antegren ms antegren antegren and the fda crohn antegren side effects antegren multiple sclerosis antegren has approved biogen antegren antegren price antegren natalizumab side effects antegren malaga antegren has approved antegren price antegren experience how to take antegren antegren + headaches antegren ms antegren and the fda antegren or antigrin antegren news antegren and ms antegren has approved antegren side effects antegren multiple sclerosis antegren and ms antegren sentinel study

abilify abraxane accolate accupril accutane acetaminophen aciphex aclovate actifed activase actiza actonel actos aczone adacel adalat adderall adipex advair advate agilect albalon albuterol aldomet alesse aleve alimta allegra aloxi alphagan alprazolam altace altocor alvesco amaryl ambien amiodarone amitriptyline amoxicillin androgel angeliq anidulafungin antabuse antegren anusol apidra apokyn arthrotec asacol aspirin atenolol ativan augmentin avandia avapro avastin avelox axid

aantegren fda approval anntegren fda approval anttegren fda approval anteegren fda approval anteggren fda approval antegrren fda approval antegreen fda approval antegrenn fda approval antegren fda approval antegren ffda approval antegren fdda approval antegren fdaa approval antegren fda approval antegren fda aapproval antegren fda appproval antegren fda appproval antegren fda apprroval antegren fda approoval antegren fda approvval antegren fda approvaal antegren fda approvall ntegren fda approval ategren fda approval anegren fda approval antgren fda approval anteren fda approval antegen fda approval antegrn fda approval antegre fda approval antegrenfda approval antegren da approval antegren fa approval antegren fd approval antegren fdaapproval antegren fda pproval antegren fda aproval antegren fda aproval antegren fda appoval antegren fda apprval antegren fda approal antegren fda approvl antegren fda approva a ntegren fda approval an tegren fda approval ant egren fda approval ante gren fda approval anteg ren fda approval antegr en fda approval antegre n fda approval antegren fda approval antegren fda approval antegren f da approval antegren fd a approval antegren fda approval antegren fda approval antegren fda a pproval antegren fda ap proval antegren fda app roval antegren fda appr oval antegren fda appro val antegren fda approv al antegren fda approva l antegren fda approval nategren fda approval atnegren fda approval anetgren fda approval antgeren fda approval antergen fda approval antegern fda approval antegrne fda approval antegre nfda approval antegrenf da approval antegren dfa approval antegren fad approval antegren fd aapproval antegren fdaa pproval antegren fda paproval antegren fda approval antegren fda aprpoval antegren fda apporval antegren fda apprvoal antegren fda approavl antegren fda approvla aantegren fda approval theantegren fda approval antegren fda approval

a b c d e f g h i k l m n o p r s t u v w x z